Navigation Links
Finding May Lead to New Drugs for Urinary Infections

Researchers seek way to destroy bad, not good, E. coli,,

FRIDAY, Feb. 20 (HealthDay News) -- Potential targets for new drugs to fight the bacteria that cause many urinary tract infections have been identified by U.S. researchers.

Two molecules called yersiniabactin and salmochelin enable E. coli to steal iron from their hosts, which makes it easier for the bacteria to survive and reproduce. Identifying the two molecules -- called siderophores -- could help lead to the development of antibiotics that target pathogenic E. coli strains without harming beneficial bacteria in the gut.

The findings appear in the Feb. 20 issue of PLoS Pathogens.

"When we treat an infection with antibiotics, it's like dropping a bomb -- nearly everything gets wiped out, regardless of whether it's helpful or harmful. We'd like to find ways to target the bad bacteria and leave the good bacteria alone, and these siderophores are a great lead in that direction," study author Jeff Henderson, of the Center for Women's Infectious Disease Research at Washington University School of Medicine in St. Louis, said in a Public Library of Science news release.

The E. coli bacteria that cause urinary tract infections might come from the human gut, where several strains of the bacteria reside. But it's believed that other strains help aid digestion and block other infectious organisms.

For their study, Henderson and his colleagues used a method called metabolomics to study the differences between disease-causing and friendly E. coli strains. Metabolomics involves analyzing all the chemicals produced by a cell, including growth signals, toxins and waste products.

"This allows us to look at the end products of many genes working together," senior study author Scott Hultgren explained in the news release. "We assess what all the various assembly lines are producing and which products disease-causing bacteria prefer to make, such as certain siderophores."

Drugs that block or disrupt the activity of the proteins that make siderophores could be one way to fight disease-causing bacteria. Another approach is what the researchers call a "Trojan horse" strategy.

"To steal iron, siderophores have to be sent out from the cell, bind to the iron and then be taken back into the cell," Henderson said. "If we can design an antibiotic that looks like a siderophore, we might be able to trick only disease-causing bacteria into taking up the drug while leaving other bacteria alone."

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about urinary tract infections.

-- Robert Preidt

SOURCE: Public Library of Science, news release, Feb. 19, 2009

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. JAMA article contends earlier study overstated validity of findings on bisphenol A
2. Findings raise new questions about evolution of hormones in mammals
3. Center for the Study of Traumatic Encephalopathy announces new findings
4. New findings on old kidneys could enhance transplants, Stanford study shows
5. Wynonna Judd Reveals Her alli(R), Her Story for Finding a Healthier Lifestyle
6. New findings shed light on why smokers struggle to quit
7. Bionovo to Present Recent Findings of BN108, its Anticancer Agent, at the 31st Annual San Antonio Breast Cancer Symposium
8. Finding Grace on a Less Traveled Road: A Cancer Doctor Reflects on Living and Dying
9. Breast cancer in men: Mammography and sonography findings
10. Initial Survey Findings on Diabetes Awareness Released by
11. Finding Points to Possible Blood Test for Brain Tumors
Post Your Comments:
Related Image:
Finding May Lead to New Drugs for Urinary Infections
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
(Date:6/24/2016)... , Belgium , June 24, ... VNRX), today announced the appointment of Dr. ... Directors as a Non-Executive Director, effective June 23, ... Audit, Compensation and Nominations and Governance Committees.  As ... Futcher will provide independent expertise and strategic counsel ...
Breaking Medicine Technology: